Publikationen, an denen er mitarbeitet AINTZANE ASUMENDI MALLEA (13)
2023
-
A Universal Antigen-Ranking Method to Design Personalized Vaccines Targeting Neoantigens against Melanoma
Life, Vol. 13, Núm. 1
-
Computational and Experimental Evaluation of the Immune Response of Neoantigens for Personalized Vaccine Design
International Journal of Molecular Sciences, Vol. 24, Núm. 10
-
Melanoma Clinical Decision Support System: An Artificial Intelligence-Based Tool to Diagnose and Predict Disease Outcome in Early-Stage Melanoma Patients
Cancers, Vol. 15, Núm. 7
-
Melanoma and Nevi Subtype Histopathological Characterization with Optical Coherence Tomography
Life, Vol. 13, Núm. 3
2022
-
Association of TYR SNP rs1042602 with Melanoma Risk and Prognosis
Life, Vol. 12, Núm. 12
2020
-
BRAF V600E mutational load as a prognosis biomarker in malignant melanoma
PLoS ONE, Vol. 15, Núm. 3
-
Serum markers improve current prediction of metastasis development in early-stage melanoma patients: a machine learning-based study
Molecular Oncology, Vol. 14, Núm. 8, pp. 1705-1718
2019
-
Imaging Mass Spectrometry–Based Lipidomic Approach to Classification of Architectural Features in Nevi
Journal of Investigative Dermatology, Vol. 139, Núm. 9, pp. 2055-2058.e7
2016
-
Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I–II early-stage melanoma
International Journal of Cancer, Vol. 139, Núm. 7, pp. 1598-1607
2014
-
Involvement of ANXA5 and ILKAP in susceptibility to malignant melanoma
PLoS ONE, Vol. 9, Núm. 4
2011
-
A customized pigmentation snp array identifies a novel snp associated with melanoma predisposition in the slc45a2 gene
PLoS ONE, Vol. 6, Núm. 4
-
Terfenadine induces apoptosis and autophagy in melanoma cells through ROS-dependent and -independent mechanisms
Apoptosis, Vol. 16, Núm. 12, pp. 1253-1267
2006
-
H1 histamine receptor antagonists induce genotoxic and caspase-2-dependent apoptosis in human melanoma cells
Carcinogenesis, Vol. 27, Núm. 9, pp. 1787-1796